Today, the U.S. Food and Drug Administration (FDA) issued a Letter to Health Care Providers to notify providers that we are aware that the United States is experiencing interruptions in the supply of neurosurgical patties, sponges and strip devices because of recent supplier issues. The FDA also updated the medical device shortage list to include neurosurgical patties, sponges and strip devices (product code HBA).
The disruption in availability of this device is expected to impact patient care and may require adjustments to the clinical management of patients receiving neurosurgery or microsurgery.
The FDA recommends health care providers consider strategies to conserve the use of neurosurgical patties, sponges & strip products when possible.
|
The Letter to Health Care Providers includes important information about the shortage of neurosurgical patties, sponges and strip devices, including:
- Recommendations for health care providers.
- Actions that the FDA is taking to assess and mitigate the risk.
- Instructions for reporting problems with a device.
